登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C8H12N4O5
化学文摘社编号:
分子量:
244.20
UNSPSC Code:
12352207
NACRES:
NA.75
PubChem Substance ID:
EC Number:
206-280-2
Beilstein/REAXYS Number:
620461
MDL number:
Form:
lyophilized powder
Quality level:
biological source
synthetic (organic)
Quality Level
grade
Hybri-Max™
sterility
γ-irradiated
product line
BioXtra
form
lyophilized powder
technique(s)
cell culture | hybridoma: suitable
impurities
endotoxin, tested
mp
226-232 °C (dec.) (lit.)
solubility
acetic acid: water (1:1): 5 mg/mL, clear, colorless
antibiotic activity spectrum
viruses
mode of action
DNA synthesis | interferes
storage temp.
−20°C
SMILES string
NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
InChI key
NMUSYJAQQFHJEW-KVTDHHQDSA-N
Gene Information
human ... DNMT1(1786), DNMT3A(1788)
General description
化学结构:核苷
Application
5-氮杂胞苷可用于诱导成人骨髓间充质干细胞的体外心肌向分化。它也可用于研究5-氮杂胞苷对骨髓来源的免疫调节性抑制细胞(MDSC)和调节性T细胞(Treg)的影响。
用于研究DNA掺入分子对DNA甲基化过程的影响。
Biochem/physiol Actions
5-氮杂胞苷是脱氧胞苷类似物和去甲基化剂。它可作为急性骨髓性白血病的潜在抗肿瘤药。5-氮杂胞苷通过抑制DNA甲基化来激活被抑制的基因。5-氮杂胞苷还通过改变RNA功能和稳定性来影响蛋白质合成。
一种强效生长抑制剂及细胞毒素剂,抑制 DNA 甲基转移酶,一种基因表达、基因激活和沉默的重要调节机制。
强效生长抑制剂及细胞毒素剂,抑制 DNA 甲基转移酶。
Preparation Note
10mL 无菌细胞培养基可复原一小瓶本品。储备液足以制备 500mL 培养基。最终工作浓度:10μM 5-氮杂胞嘧啶核苷。
Legal Information
Hybri-Max is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 5-阿扎胞苷
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 1A - Muta. 2 - Repr. 1B - STOT RE 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
ppe
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
DNA methyltransferase inhibitors for cancer therapy
Epigenetics, 5(3), 265-290 (2015)
5-azacytidine treatment reorganizes genomic histone modification patterns
Komashko VM and Farnham PJ
Epigenetics, 5(3), 229-240 (2010)
Rena Buckstein et al.
Cancer treatment reviews, 37(2), 160-167 (2010-07-02)
Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoiesis that results in peripheral blood cytopenias and a marked propensity to progress to acute myelogenous leukemia. With 40,000-76,000 new cases per year in the USA, MDS is the commonest of the
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| A1287-1VL | 04061833342046 |


